Skip to content

MediSapiens Supports Bayer’s Future Clinical Trial Program (Updated)

NewsBy estate@medisapiens.fi30.6.2021

MediSapiens supports Bayer in its Future Clinical Trials program, where Bayer is working to transform clinical trials with data science and patient-centricity. MediSapiens provides its data model knowledge (such as OMOP), data quality capabilities and data management know-how to Bayer, among others. To hear more, listen to Bayer’s Jussi Leinonen present the Future Clinical Trials…

© 2023 GSS Software Suite. All rights reserved.
Go to Top